| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;43:1074.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
From the Departments of Internal Medicine (M.J.R., S.P.D., S.M. F.M.F., C.D.S.), Pharmacology (F.M.F.), and Physiology and Biophysics (C.D.S.), Cardiovascular Center, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City.
Correspondence to Michael J. Ryan, PhD, Department of Internal Medicine, University of Iowa, 3181 MEBRF, Iowa City, IA 52242. E-mail ryanm{at}physiology.uiowa.edu
Many of the actions of angiotensin II (Ang II) are mediated by angiotensin type 1 receptors (AT1), of which there are 2 pharmacologically indistinguishable subtypes (AT1A and AT1B). The purpose of this study was to evaluate the effect of an AT1A homozygous deletion (AT1A/) on vascular reactivity. AT1A/ mice and control littermates (AT1A+/+) were infused with vehicle (saline) or Ang II (1000 ng · kg1 · min1) for 7 days by osmotic pumps. Systolic pressure was increased in AT1A+/+ mice (
45±8 mm Hg, P<0.0001) but unchanged in AT1A/ mice (
5±3 mm Hg, P>0.13) on day 7. The carotid artery response to the vasodilators acetylcholine (ACh), nitroprusside, and papaverine and to the vasoconstrictors phenylephrine, U46619, 5-hydroxytryptamine (5-HT), and KCl were not different between vehicle-infused AT1A+/+ and AT1A/ animals. Carotid relaxation to ACh was impaired and contraction to 5-HT was increased in Ang IIinfused AT1A+/+ mice. Ang II did not affect carotid responses in AT1A/ mice. Superoxide, measured by lucigenin (5 µmol/L), and hydroethidine staining were not different between AT1A+/+ and AT1A/ mice after vehicle or Ang II infusion, suggesting that it was not contributing to the altered ACh and 5-HT responses. The Rho-kinase inhibitor Y-27632 (1 µmol/L) attenuated the 5-HT response in both vehicle- and Ang IIinfused AT1A+/+ mice. Moreover, concentration-dependent relaxation to Y-27632 and RhoA protein expression were not different in vehicle- or Ang IIinfused AT1A+/+. These data demonstrate that the AT1A receptor is required for Ang IIinduced changes in carotid artery function.
Key Words: endothelium receptors, angiotensin II carotid arteries acetylcholine
This article has been cited by other articles:
![]() |
S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, Y. Chu, and F. M. Faraci Endogenous Interleukin-10 Inhibits Angiotensin II-Induced Vascular Dysfunction Hypertension, September 1, 2009; 54(3): 619 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Schrader, D. A. Kinzenbaw, A. W. Johnson, F. M. Faraci, and S. P. Didion IL-6 Deficiency Protects Against Angiotensin II Induced Endothelial Dysfunction and Hypertrophy Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2576 - 2581. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Hercule, J. Tank, R. Plehm, M. Wellner, A. C. da Costa Goncalves, M. Gollasch, A. Diedrich, J. Jordan, F. C. Luft, and V. Gross Cardiovascular Control: Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice Exp Physiol, November 1, 2007; 92(6): 1014 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Zemse, R. H. P. Hilgers, and R. C. Webb Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3103 - H3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, C. M. Lynch, and F. M. Faraci Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1579 - H1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II Arterioscler Thromb Vasc Biol, February 1, 2007; 27(2): 303 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ryan and G. R. McLemore Jr. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R736 - R742. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ohtsu, H. Suzuki, H. Nakashima, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi Angiotensin II Signal Transduction Through Small GTP-Binding Proteins: Mechanism and Significance in Vascular Smooth Muscle Cells Hypertension, October 1, 2006; 48(4): 534 - 540. [Full Text] [PDF] |
||||
![]() |
L. M. Harrison-Bernard, C. J. Monjure, and B. J. Bivona Efferent arterioles exclusively express the subtype 1A angiotensin receptor: functional insights from genetic mouse models Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1177 - F1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola Angiotensin II Attenuates Endothelium-Dependent Responses in the Cerebral Microcirculation Through Nox-2-Derived Radicals Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 826 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, D. A. Kinzenbaw, and F. M. Faraci Critical Role for CuZn-Superoxide Dismutase in Preventing Angiotensin II-Induced Endothelial Dysfunction Hypertension, November 1, 2005; 46(5): 1147 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wesseling, D. A. Ishola Jr., J. A. Joles, H. A. Bluyssen, H. A. Koomans, and B. Braam Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1191 - F1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Barnes, E. Reiter, J. D. Violin, X.-R. Ren, G. Milligan, and R. J. Lefkowitz {beta}-Arrestin 1 and G{alpha}q/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation J. Biol. Chem., March 4, 2005; 280(9): 8041 - 8050. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vazquez, M. F. C. de Adjounian, C. Sumners, A. Gonzalez, C. Diez-Freire, and M. K. Raizada Selective Silencing of Angiotensin Receptor Subtype 1a (AT1aR) by RNA Interference Hypertension, January 1, 2005; 45(1): 115 - 119. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |